Important new role for aspirin: prevention of recurrent thromboembolism: ASPIRE findings
Timothy Brighton
/
RSS Feed
Timothy Brighton
LOS ANGELES—Aspirin has a new role: in preventing recurrent thromboembolism among patients who are not candidates for anti-coagulation — according to conclusions from the ASPIRE study reported to the American Heart Association’s 2012 Scientific Sessions. Dr Timothy Brighton of the Prince of Wales Hospital and the University of Sydney in Australia discussed the study findings with Sarah Maxwell.
LISTEN
[audio:https://www.audiomedica.com/podcasting/aha/121111TimothyBrightonPODCASTLoRes.mp3]
You may also like...
Human Growth Hormone: Responses in Severe Heart Failure 17 Nov, 2005 - Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI 5 Nov, 2007
- Primary PCI: Better in the Real World, Too 17 Nov, 2005
- GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension 10 Feb, 2007
